Kwabena Kyei - Boston, Massachusetts 02118

Kwabena Kyei is categorized under Doctors in Boston, MA .

Business Name: Kwabena Kyei
Contact Person: Kwabena Kyei
Address: 850 Harrison Avenue, Boston, Massachusetts 02118
Phone Number: (617) 414-4893
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Cove Christina MD - Boston, MA 02118
Boston University Dermatology - Boston, MA 02118
Cohen Mardge H MD - Boston, MA 02118
Boston University Med Group - Boston, MA 02118
Blazek Jr William V MD - Boston, MA 02118
Alikhan Mir M MD - Boston, MA 02118
Cardiovascular Medicine - Boston, MA 02118
Barron William M MD - Boston, MA 02118
Ballard Dwan Jennifer E MD - Boston, MA 02118
Chiakpo Evelyne N MD - Boston, MA 02118
Blenner Stephanie L MD - Boston, MA 02118
Chin Lawrence S MD - Boston, MA 02118
Cancer Research Center - Boston, MA 02118
Cowan Andrew J MD - Boston, MA 02118
Conlin Jane L MD - Boston, MA 02118
Caicedo Marco L MD - Boston, MA 02118
Burgos-Chapman Isis I MD - Boston, MA 02118
Boston Univ Med Center Urologists - Boston, MA 02118
Carine Lenders - Boston, MA 02118
Boston University Med Group - Boston, MA 02118

The company Kwabena Kyei provides B2C services in the form of Doctors from its single location in Massachusetts. 1 to 4 employees work for Kwabena Kyei, and the business now earns $100.000 to $499.999 per annum.

Kwabena Kyei was launched in 2001 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Kwabena Kyei, please call Kwabena Kyei with the phone number (617) 414-4893 or visit its single location at 850 Harrison Avenue in Boston, Massachusetts 02118.

The location of the single location can also be found using the coordinates 42.335211,-71.074528. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.